Edition:
India

People: Albireo Pharma Inc (ALBO.OQ)

ALBO.OQ on NASDAQ Stock Exchange Capital Market

25.45USD
1:30am IST
Change (% chg)

$-0.32 (-1.24%)
Prev Close
$25.77
Open
$25.60
Day's High
$26.30
Day's Low
$25.31
Volume
19,843
Avg. Vol
17,925
52-wk High
$38.48
52-wk Low
$19.43

Horn, Patrick 

Dr. Patrick T. Horn M.D. Ph.D. is the Chief Medical Officer of Albireo Pharma Inc., effective August 6, 2018. He has served as our Chief Medical Officer since August 2018. He previously served as Senior Vice President, Medical and Clinical Development at Orphan Technologies Ltd., a biopharmaceutical company, from January 2018 to July 2018. Prior to that, he served as Chief Medical Officer at Tetraphase Pharmaceuticals, Inc., a biopharmaceutical company, from January 2011 to December 2017. Prior to that, he served as Vice President, Clinical & Medical Affairs at Dyax Corporation, a biopharmaceutical company, from September 2007 to December 2010. Previously, Dr. Horn served in various positions at Abbott Laboratories, a pharmaceutical company, from 2001 to 2006, most recently serving as Medical Director, Head of Clinical Pharmacology. Dr. Horn received a B.S. in Chemistry from the University of Illinois, a Ph.D. in the Pharmacological and Physiological Sciences from the University of Chicago and an M.D. from the University of Chicago, Pritzker School of Medicine.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

David Chiswell

195,084

Ronald Cooper

3,618,630

Simon Harford

--

Jan Mattsson

1,404,280

Martha Carter

1,243,480

Patrick Horn

--
As Of  31 Dec 2018